Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
12.34
+0.51 (4.31%)
Dec 20, 2024, 4:00 PM EST - Market closed
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $614.15 million as of December 20, 2024. Its market cap has increased by 116.53% in one year.
Market Cap
614.15M
Enterprise Value
350.54M
1-Year Change
116.53%
Ranking
Category
Stock Price
$12.34
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has decreased from $624.91M to $614.15M, a decrease of -1.72%. That is a compound annual growth rate of -0.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 614.15M | 73.73% |
| Dec 29, 2023 | 353.50M | -43.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CureVac | 643.78M |
| Entrada Therapeutics | 622.78M |
| Pharming Group | 622.18M |
| Stoke Therapeutics | 618.65M |
| GRAIL | 616.57M |
| Autolus Therapeutics | 609.42M |
| Arbutus Biopharma | 608.27M |
| Omeros | 597.46M |